(Q40645298)

22 September 2017

1 reference

title

Renin inhibition: a new approach to cardiovascular therapy (English)

1 reference

22 September 2017

Frishman WH

1

1 reference

22 September 2017

Fozailoff A

series ordinal

2

1 reference

22 September 2017

Lin C

series ordinal

3

1 reference

22 September 2017

Dike C

series ordinal

4

1 reference

22 September 2017

publication date

1 September 1994

1 reference

The Journal of Clinical Pharmacology

22 September 2017

published in

1 reference

22 September 2017

volume

34

1 reference

22 September 2017

issue

9

1 reference

22 September 2017

page(s)

873-880

1 reference

Molecular basis of human hypertension: role of angiotensinogen

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB04000.X

Synthesis of peptides related to the prosegment of mouse submaxillary gland renin precursor: an approach to renin inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB04000.X

Inhibition of aspartic proteases by pepstatin and 3-methylstatine derivatives of pepstatin. Evidence for collected-substrate enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB04000.X

Competitive inhibitors of renin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB04000.X

Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB04000.X

Potent new inhibitors of human renin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB04000.X

Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB04000.X

Design of rat renin inhibitory peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB04000.X

Pharmacological investigations of a new renin inhibitor in normal sodium-unrestricted volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB04000.X

Renin inhibitors. Design and synthesis of a new class of conformationally restricted analogues of angiotensinogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB04000.X

Discovery of a peptide-based renin inhibitor with oral bioavailability and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB04000.X

Discovery of a well-absorbed, efficacious renin inhibitor, A-74273

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB04000.X

Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB04000.X

Lewis K. Dahl Memorial Lecture. The renin system and four lines fo hypertension research. Nephron heterogeneity, the calcium connection, the prorenin vasodilator limb, and plasma renin and heart attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB04000.X

Novel renin inhibitors containing the amino acid statine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB04000.X

Peptide Inhibitors of the Renin–Angiotensin System

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB04000.X

10.1002/J.1552-4604.1994.TB04000.X

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference